1-3 of 3
David S. Small, PhD
Close
Sort by
Journal Articles

Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study

Lori Styles, MD, Joseph A. Jakubowski, PhD, Darell E. Heiselman, MD, Lori E. Heath, MS, Chunmei Zhou, MS, Charles T. Quinn, MD, MS, Matthew M. Heeney, MD, Rupa Redding-Lallinger, MD, David S. Small, PhD, Brian A. Moser, MS, Kenneth J. Winters, MD
Journal: Blood
Blood (2012) 120 (21): 3213.
https://doi.org/10.1182/blood.V120.21.3213.3213
Published: 2012
Journal Articles

A Phase 1 Study of Prasugrel in Subjects with Sickle Cell Disease: Impact on Ex Vivo Platelet Reactivity

Joseph A. Jakubowski, PhD, Chunmei Zhou, MS, David S. Small, PhD, Kenneth J. Winters, MD, D. Richard Lachno, DPhil, Andrew L. Frelinger, III, PhD, Jo Howard, MB, BChir, MRCP, FRCPath, Stipo Jurcevic, MD, Christopher D. Payne, MSc
Journal: Blood
Blood (2011) 118 (21): 1053.
https://doi.org/10.1182/blood.V118.21.1053.1053
Published: 2011
Journal Articles

A Phase 1 Study of Prasugrel in Subjects with Sickle Cell Disease: Effects on In Vivo Markers of Platelet Activation and of Coagulation

Joseph A. Jakubowski, PhD, Chunmei Zhou, MS, David S. Small, PhD, Kenneth J. Winters, MD, D. Richard Lachno, DPhil, Andrew L. Frelinger, III, PhD, Jo Howard, MB, BChir, MRCP, FRCPath, Stipo Jurcevic, MD, Christopher D. Payne, MSc
Journal: Blood
Blood (2011) 118 (21): 1049.
https://doi.org/10.1182/blood.V118.21.1049.1049
Published: 2011